Stryker to announce financial results for its second quarter of fiscal year 2025GlobeNewsWire • 07/01/25
SYK Boosts Foot & Ankle Portfolio With FDA-Cleared Total Ankle SystemZacks Investment Research • 06/30/25
SYK Stock Likely to Rise Following FDA Clearance for OptaBlate SystemZacks Investment Research • 05/20/25
Stryker receives FDA clearance for OptaBlate® BVN Basivertebral Nerve Ablation SystemPRNewsWire • 05/19/25
Stryker Corporation (SYK) Bank of America Securities 2025 Global Healthcare Conference (Transcript)Seeking Alpha • 05/14/25
Billionaire Terry Smith, "the English Warren Buffett," Has 31% of His Hedge Fund's Portfolio Invested in 3 Exceptional StocksThe Motley Fool • 05/10/25
SYK Stock Falls Despite Q1 Earnings & Sales Beat on Lower '25 EPS ViewZacks Investment Research • 05/02/25
MedTech Stocks' Earnings to Watch on May 1: BDX, CAH, BAX, DXCM & SYKZacks Investment Research • 04/30/25
Stryker to participate in the Bank of America Securities 2025 Global Healthcare ConferenceGlobeNewsWire • 04/29/25
Gear Up for Stryker (SYK) Q1 Earnings: Wall Street Estimates for Key MetricsZacks Investment Research • 04/28/25
Stryker (SYK) Reports Next Week: Wall Street Expects Earnings GrowthZacks Investment Research • 04/24/25
The Zacks Analyst Blog Bank of America, Chevron, Stryker, Value Line and SyprisZacks Investment Research • 04/15/25